Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viridian Therapeutics, Inc.

13.02
+0.63005.08%
Volume:12.76K
Turnover:165.02K
Market Cap:1.06B
PE:-3.91
High:13.02
Open:12.82
Low:12.76
Close:12.39
Loading ...

Viridian Therapeutics- Veligrotug Met All Primary and Secondary Endpoints in Pivotal Thrive and Thrive-2 Clinical Trials in Active and Chronic Ted

THOMSON REUTERS
·
08 May

Viridian Therapeutics- Bla Submission for Veligrotug on Track for Second Half 2025 With a Planned U.S. Launch in 2026, IF Approved

THOMSON REUTERS
·
08 May

Viridian Therapeutics Receives FDA Breakthrough Therapy Designation for Veligrotug for the Treatment of Thyroid Eye Disease (Ted)

THOMSON REUTERS
·
08 May

Sector Update: Health Care Stocks Lower in Afternoon Trading

MT Newswires Live
·
07 May

Viridian Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Earnings Flash (VRDN) Viridian Therapeutics Posts Q1 Net Loss $0.87 a Share, vs. FactSet Est of $1 Loss

MT Newswires Live
·
06 May

BRIEF-Viridian Therapeutics Q1 Net Income USD -86.912 Million

Reuters
·
06 May

Viridian Therapeutics - Cash Position of $636.6 Mln as of March 31, 2025, Which Supports Cash Runway Into Second Half of 2027

THOMSON REUTERS
·
06 May

Viridian Therapeutics Q1 Cash & Investments USD 636.6 Million

THOMSON REUTERS
·
06 May

Viridian Therapeutics - Q1 Net Loss per Share, Series B Preferred Stock $ 57.94

THOMSON REUTERS
·
06 May

Press Release: Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2025 Financial Results

Dow Jones
·
06 May

BRIEF-Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

Reuters
·
02 May

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 May

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
02 May

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live
·
11 Apr

Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Viridian Therapeutics (VRDN)

TIPRANKS
·
04 Apr

BRIEF-Viridian Therapeutics Terminates Prior $175 Million Sale Agreement

Reuters
·
04 Mar